Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.12 USD | -0.16% | +6.51% | -1.87% |
04-29 | North American Morning Briefing : Investors Brace -2- | DJ |
03-25 | Cassava Sciences Announces Completion of Interim Safety Review for Alzheimer's Drug Candidate Simufilam | MT |
- Stock Market
- Equities
- SAVA Stock
- News Cassava Sciences, Inc.
- Other languages